Detection of subclinical tubular injury after renal transplantation: Comparison of urine protein analysis with allograft histopathology

Transplantation

Volumn 84, Issue 1, 2007, Pages 104-112

  Schaub, Stefan ^a   Mayr, Michael ^a   Hönger, Gideon ^a   Bestland, Jennifer ^b   Steiger, Jürg ^a   Regeniter, Axel ^a   Mihatsch, Michael J ^c   Wilkins, John A ^b   Rush, David ^b   Nickerson, Peter ^b  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY OF MANITOBA   (Canada)

^c UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Noninvasive monitoring; Protocol biopsy; Renal allograft rejection; Tubular injury; Urine proteins

Indexed keywords

ALPHA 1 MICROGLOBULIN; BETA 2 MICROGLOBULIN; BIOLOGICAL MARKER; LIPOCALIN; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; RETINOL BINDING PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ALLOGRAFT; ARTICLE; CONTROLLED STUDY; FEMALE; HISTOLOGY; HISTOPATHOLOGY; HUMAN; KIDNEY BIOPSY; KIDNEY TRANSPLANTATION; KIDNEY TUBULE DAMAGE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN URINE LEVEL; PROTEINURIA; SCREENING; URINALYSIS;

ACUTE-PHASE PROTEINS; ADULT; AGED; ALBUMINURIA; ALPHA-MACROGLOBULINS; BETA 2-MICROGLOBULIN; BIOLOGICAL MARKERS; BIOPSY; FEMALE; GRAFT REJECTION; HUMANS; HYDROGEN-ION CONCENTRATION; KIDNEY; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; KIDNEY TUBULES; MALE; MIDDLE AGED; PROTO-ONCOGENE PROTEINS; RETINOL-BINDING PROTEINS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TRANSPLANTATION, HOMOLOGOUS;

EID: 34447642181     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000268808.39401.e8     Document Type: Article

References (42)

1. Nankivell BJ, Borrows RJ, Fung CL, et al. The natural history of chronic allograft nephropathy. N Engl J Med 2003; 349: 2326.
2. Nankivell BJ, Borrows RJ, Fung CL, et al. Delta analysis of posttransplantation tubulointerstitial damage. Transplantation 2004; 78: 434.
3. Robertson H, Ali S, McDonnell BJ, et al. Chronic renal allograft dysfunction: The role of T cell-mediated tubular epithelial to mesenchymal cell transition. J Am Soc Nephrol 2004; 15: 390.
4. Cosio FG, Grande JP, Larson TS, et al. Kidney allograft fibrosis and atrophy early after living donor transplantation. Am J Transplant 2005; 5: 1130.
5. Cosio FG, Grande JP, Wadei H, et al. Predicting subsequent decline in kidney allograft function from early surveillance biopsies. Am J Transplant 2005; 5: 2464.
6. Moreso F, Ibernon M, Goma M, et al. Subclinical rejection associated with chronic allograft nephropathy in protocol biopsies as a risk factor for late graft loss. Am J Transplant 2006; 6: 747.
7. Grimm PC, Nickerson P, Gough J, et al. Computerized image analysis of sirius red-stained renal allograft biopsies as a surrogate marker to predict long-term allograft function. J Am Soc Nephrol 2003; 14: 1662.
8. Rush D, Nickerson P, Gough J, et al. Beneficial effects of treatment of early subclinical rejection: A randomized study. J Am Soc Nephrol 1998; 9: 2129.
9. Meier-Kriesche HU, Schold JD, Srinivas TR, Kaplan B. Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era. Am J Transplant 2004; 4: 378.
10. Gloor JM, Cohen AJ, Lager DJ, et al. Subclinical rejection in tacrolimus-treated renal transplant recipients. Transplantation 2002; 73: 1965.
11. Rush DN, Henry SF, Jeffery JR, et al. Histological findings in early routine biopsies of stable renal allograft recipients. Transplantation 1994; 57: 208.
12. Rush D. Protocol transplant biopsies: An underutilized tool in kidney transplantation. Clin J Am Soc Nephrol 2006; 1: 138.
13. Schaub S, Rush D, Wilkins J, et al. Proteomic-based detection of urine proteins associated with acute renal allograft rejection. J Am Soc Nephrol 2004; 15: 219.
14. Schaub S, Wilkins JA, Antonovici M, et al. Proteomic-based identification of cleaved urinary β2-microglobulin as a potential marker for acute tubular injury in renal allografts. Am J Transplant 2005; 5: 729.
15. Racusen LC, Colvin RB, Solez K, et al. Antibody-mediated rejection criteria: An addition to the Banff 97 classification of renal allograft rejection. Am J Transplant 2003; 3: 708.
16. Regeniter A, Siede WH, Scholer A, et al. Interpreting complex urinary patterns with MDI LABLINK: A statistical evaluation. Clin Chim Acta 2000; 297: 261.
17. Regeniter A, Steiger JU, Scholer A, et al. Windows to the ward: Graphically oriented report forms. Presentation of complex, interrelated laboratory data for electrophoresis/immunofixation, cerebrospinal fluid, and urinary protein profiles. Clin Chem 2003; 49: 41.
18. Mishra J, Dent C, Tarabishi R, et al. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet 2005; 365: 1231.
19. Antibodyshop. Available at: www.antibodyshop.com. NGAL ELISA Kit (KIT 036) product inlay. 2006.
20. Schardijn GH, Statius van Eps LW, Pauw W, et al. Comparison of reliability of tests to distinguish upper from lower urinary tract infection. BMJ (Clin Res Ed) 1984; 289: 284.
21. Woo KT, Lee EJ, Lau YK, Lim CH. β2-microglobulin in the assessment of renal function of the transplanted kidney. Nephron 1985; 39: 223.
22. Penders J, Delanghe JR. Alpha 1-microglobulin: Clinical laboratory aspects and applications. Clin Chim Acta 2004; 346: 107.
23. Mori K, Lee HT, Rapoport D, et al. Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury. J Clin Invest 2005; 115: 610.
24. Parikh CR, Jani A, Mishra J, et al. Urine NGAL and IL-18 are predictive biomarkers for delayed graft function following kidney transplantation. Am J Transplant 2006; 6: 1639.
25. Zolg W. The proteomic search for diagnostic biomarkers: Lost in translation? Mol Cell Proteomics 2006; 5: 1720.
26. Blumsohn A, Morris BW, Griffiths H, Ramsey CF. Stability of β2-microglobulin and retinol binding protein at different values of pH and temperature in normal and pathological urine. Clin Chim Acta 1991; 195: 133.
27. Herget-Rosenthal S, Poppen D, Husing J, et al. Prognostic value of tubular proteinuria and enzymuria in nonoliguric acute tubular necrosis. Clin Chem 2004; 50: 552.
28. Oetting WS, Rogers TB, Krick TP, et al. Urinary β2-microglobulin is associated with acute renal allograft rejection.AmJ Kidney Dis 2006; 47: 898.
29. Yamamoto H, Yamada T, Itoh Y. Probable involvement of cathepsin D in the degradation of β2-microglobulin in acidic urine. Clin Chem Lab Med 2000; 38: 495.
30. Villanueva J, Shaffer DR, Philip J, et al. Differential exoprotease activities confer tumor-specific serum peptidome patterns. J Clin Invest 2006; 116: 271.
31. Artz MA, Dooper PM, Meuleman EJ, et al. Time course of proteinuria after living-donor kidney transplantation. Transplantation 2003; 76: 421.
32. Teppo AM, Honkanen E, Ahonen J, Gronhagen-Riska C. Changes of urinary α1-microglobulin in the assessment of prognosis in renal transplant recipients. Transplantation 2000; 70: 1154.
33. Myslak M, Am H, Morales P, et al. Interpreting post-transplant proteinuria in patients with proteinuria pre-transplant. Am J Transplant 2006; 6: 1660.
34. Nicholson ML, Wheatley TJ, Doughman TM, et al. A prospective randomized trial of three different sizes of core-cutting needle for renal transplant biopsy. Kidney Int 2000; 58: 390.
35. Sorof JM, Vartanian RK, Olson JL, et al. Histopathological concordance of paired renal allograft biopsy cores. Effect on the diagnosis and management of acute rejection. Transplantation 1995; 60: 1215.
36. Camara NO, Silva MS, Nishida S, et al. Proximal tubular dysfunction is associated with chronic allograft nephropathy and decreased long-term renal-graft survival. Transplantation 2004; 78: 269.
37. Teppo AM, Honkanen E, Finne P, et al. Increased urinary excretion of α1-microglobulin at 6 months after trasnplantation is associated with urinary excretion of transforming growth factor-á1 and indicates poor long-term renal outcome. Transplantation 2004; 78: 719.
38. Rush D, for the FKC008 Study Group. No benefit of protocol biopsies in renal transplant patients receiving tacrolimus and mycophenolate mofetil: A multicentre randomized study.AmJ Transplant 2006; 6(S2): 351.
39. Vitalone M, O'Connell PJ, Fung C et al. Epithelial-to-mesenchymal transition in chronic allograft nephropathy. Am J Transplant 2006; 6(S2): 351.
40. Hertig A, Verine J, Mougenot B et al. Risk factors for early epithelial to mesenchymal transition in renal grafts. Am J Transplant 2006; 6: 2937.
41. Schaub S, Wilkins JA, Rush D, Nickerson P. Developing a tool for noninvasive monitoring of renal allografts. Expert Rev Proteomics 2006; 3: 497.
42. Hewitt SM, Dear J, Star RA. Discovery of protein biomarkers for renal diseases. J Am Soc Nephrol 2004; 15: 1677.